Literature DB >> 12595294

Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR.

Lynne Turnbull1, Diana T McCloskey, Timothy D O'Connell, Paul C Simpson, Anthony J Baker.   

Abstract

Two functional alpha(1)-adrenergic receptor (AR) subtypes (alpha(1A) and alpha(1B)) have been identified in the mouse heart. However, it is unclear whether the third known subtype, alpha(1D)-AR, is also present. To investigate this, we determined whether there were alpha(1)-AR responses in hearts from a novel mouse model lacking alpha(1A)- and alpha(1B)-ARs (double knockout) (ABKO). In Langendorff-perfused hearts, alpha(1)-ARs were stimulated with phenylephrine. For ABKO hearts, phenylephrine reduced left ventricular pressure and coronary flow (to 87 +/- 2% and 86 +/- 4% of initial, respectively, n = 11, P < 0.01). These effects were blocked by prazosin and 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-8-azaspirol[4,5]decane-7,9-dione] dihydrochloride, suggesting that alpha(1D)-AR-mediated responses were present. In contrast, right ventricular trabeculae from ABKO hearts did not respond to phenylephrine, suggesting that in ABKO perfused hearts, the effects of phenylephrine were not mediated by direct actions on cardiomyocytes. A novel finding was that alpha(1)-AR stimulation caused positive inotropy in the wild-type mouse heart, in contrast to negative inotropy observed in mouse cardiac muscle strips. We conclude that mouse hearts lacking alpha(1A)- and alpha(1B)-ARs retain functional alpha(1)-AR responses involving decreases of coronary flow and ventricular pressure that reflect alpha(1D)-AR-mediated vasoconstriction. Furthermore, alpha(1)-AR inotropic responses depend critically on the experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12595294     DOI: 10.1152/ajpheart.00441.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  26 in total

1.  Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes.

Authors:  Casey D Wright; Quanhai Chen; Nichole L Baye; Yuan Huang; Chastity L Healy; Sivakanthan Kasinathan; Timothy D O'Connell
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

2.  Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes.

Authors:  L Methven; P C Simpson; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.

Authors:  Monte S Willis; Amro Ilaiwy; Megan D Montgomery; Paul C Simpson; Brian C Jensen
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

4.  The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling.

Authors:  Michael Grimm; Nina Mahnecke; Friederike Soja; Ali El-Armouche; Pascal Haas; Hendrik Treede; Hermann Reichenspurner; Thomas Eschenhagen
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

5.  Human Myocardium Has a Robust α1A-Subtype Adrenergic Receptor Inotropic Response.

Authors:  Paul M L Janssen; Benjamin D Canan; Ahmet Kilic; Bryan A Whitson; Anthony J Baker
Journal:  J Cardiovasc Pharmacol       Date:  2018-09       Impact factor: 3.105

6.  Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Sally Turcato; Susan Nicholas; Richard Tu; Bo-Qing Zhu; John Cha; Philip M Swigart; Bat-Erdene Myagmar; Anthony J Baker; Paul C Simpson; Michael J Mann
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

7.  Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.

Authors:  Timothy D O'Connell; Philip M Swigart; M C Rodrigo; Shinji Ishizaka; Shuji Joho; Lynne Turnbull; Laurence H Tecott; Anthony J Baker; Elyse Foster; William Grossman; Paul C Simpson
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

8.  The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries.

Authors:  Brian C Jensen; Philip M Swigart; Marie-Eve Laden; Teresa DeMarco; Charles Hoopes; Paul C Simpson
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

Review 9.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

10.  The alpha 1B/D-adrenoceptor knockout mouse permits isolation of the vascular alpha 1A-adrenoceptor and elucidates its relationship to the other subtypes.

Authors:  L Methven; M McBride; G A Wallace; J C McGrath
Journal:  Br J Pharmacol       Date:  2009-06-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.